Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies. (PRIERR)
The investigators previously showed that both antibody class switching (from IgM to IgG, IgA or IgE) and antibody secretion are controlled by a polymorphic "3' regulatory region" (3'RR) of the immunoglobulin heavy chain (IgH) locus. Alleles of the 3'RR have shown influences on the severity and progression of IgA nephropathy (IgAN) (with an over-representation of the B allele among patients with severe kidney IgA deposits). Allele B also constitutes a risk factor for celiac disease, herpetiform dermatitis, psoriasis and rheumatoid arthritis. Since the 3'RR now appears as a crucial regulator of Ig production, we wish to check whether its genetic polymorphism might influence not only the occurrence of immunopathologic processes involving class-switched antibody deregulated production but also the severity of such diseases or the time course of their progression. We wish to focus on two conditions involving class-switched antibodies: on one hand the severe forms of IgE hypersensitivities, and on the other hand a disease involving pathogenic IgA and for which the prognosis is currently very difficult to predict at the onset of the disease: Henoch-Schonlein purpura (HSP).
Regarding hypersensitivities, the diversity of their clinical manifestations prompt us to focus on homogeneous groups of patients and we thus wish to concentrate on two groups of patients who are frequently referred to the hospital: severe allergies to Hymenoptera venoms and severe food allergies related to peanut allergens sensitization. These groups will be built by considering multiple clinical criteria (clinical history, severity of the manifestations, positive skin tests, and positive oral provocation tests for peanut allergens…) and biological criteria authenticating the mechanisms of the disease (high specific serum IgE, demonstration of specific basophil activation by the allergen…).
In parallel to the study in patients, we will include a large cohort of healthy controls (400 individuals), in order to be able to decipher whether correlations can be seen between:
- IgH 3'RR genotypes
- The serum accumulation of the various Ig classes, including IgG subclasses, IgA (which are sometimes depicted as protective, sometimes as tolerogenic and anti-inflammatory) and IgE (highly pro-inflammatory and responsible for hypersensitivities)
- IgG allotypes (with 6 frequent IgG haplotypes known in human and previously reported as correlated with varying levels of IgG and IgE production in normal individuals).
研究概览
详细说明
This study should thus finally provide answers to 5 questions which are currently un-addressed:
- How the 3'RR alleles are linked to IgG allotypes and corresponding IgH haplotypes?
- Is there a physiological link between 3'RR alleles and production of the various Ig classes and sub-classes?
- Is the 3'RR polymorphism connected with the risk of more severe forms of allergic diseases?
- Is the 3'RR polymorphism connected with the risk of occurrence and/or severe evolution of HSP?
- Is the oncogenicity of translocations affecting the IgH locus connected to the strength of the 3'RR allelic variants?
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Limoges、法国、87042
- Clinical Investigation Center
-
Limoges、法国、87042
- Nephrology
-
Limoges、法国、87042
- Pediatric
-
Limoges、法国、87042
- Pneumology
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
4 populations :
- Healthy Volunteers
- subjects with HPS
- subjects with peanut allergy or hymenoptera venom allergy
- lymphoma (biological collection)
描述
Inclusion Criteria:
- Healthy Volunteers:
Age ≥ 18 and < 50 years No history of allergy, haematological malignancies or immune diseases
- Subjects with allergy:
- Children:
Age ≥ 4 and < 18 years Clinical history supporting the diagnosis of severe food allergy Peanut specific IgE (Arah2) -Adults: Age > 18 and < 60 years History of severe reaction after antigenic challenge Anaphylactic shock already experienced Specific IgE or positive BAT Positive prick tests
- subject with HPS:
- Children:
Age ≥ 4 and < 18 years Henoch Schonlein Purpura (HSP) documented by Ankara 2008 criteria
-Adult: Henoch Schonlein Purpura(HSP) with renal involvement Adults ≥ 18 years,
Exclusion Criteria:
- subject with allergy or subject with Henoch Schonlein Purpura(HSP): known pregnancy patient under guardianship
- Healthy Volunteers:
Allergy known pregnancy patient under guardianship
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Children with HSP
children with Purpura of Henoch-Schönlein with or without renal complication
|
Dosage of Ig
|
|
healthy volunteers
healthy volunteers without allergy
|
Dosage of Ig
|
|
subjects with allergy
subjects with peanut allergy or hymenoptera venom allergy
|
Dosage of Ig
|
|
lymphoma
lymphoma-proliferation with chromosome 14 translocation
|
Dosage of Ig
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
the percentage of allele B
大体时间:one day
|
A comparison will be made of the percentage of allele B between healthy volunteers and the three cohorts of subjects with various diseases: (1) lymphoma (lymphoma-proliferation with chromosome 14 translocation ), (2) Henoch-Schonlein purpura HSP (3), allergy (peanut and Hymenoptera venom)
|
one day
|
合作者和调查者
合作者
调查人员
- 首席研究员:Michel COGNE, MD、Limoges UH
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.